Heart rate dynamics in doxorubicin-induced cardiomyopathy

Physiological Measurement

Volumn 36, Issue 4, 2015, Pages 727-739

  Loncar Turukalo T ^a   Vasic M ^b   Tasic T ^b   Mijatovic G ^a   Glumac, S ^b   Bajic D ^a   Japunzic Zigon N ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

37M10 time series analysis; cardiotoxicity; doxorubicin; heart rate variability; HilbertHuang transform; MSC 92C30 physiology

Indexed keywords

ECHOCARDIOGRAPHY; HEART; MATHEMATICAL TRANSFORMATIONS; TIME SERIES ANALYSIS;

37M10 TIME SERIES ANALYSE; CARDIOTOXICITY; CLINICAL USE; DOXORUBICIN; HEART RATE VARIABILITY; HEART-RATE DYNAMICS; HILBERT HUANG TRANSFORMS; MSC 92C30 PHYSIOLOGY; TIME-FREQUENCY ANALYSIS; TIME-SERIES ANALYSIS;

RATS;

RATTUS; RATTUS NORVEGICUS;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN;

ANIMAL; CARDIOMYOPATHIES; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART; HEART MUSCLE; HEART RATE; KAPLAN MEIER METHOD; MALE; OUTBRED STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL PROCESSING; WISTAR RAT;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DOXORUBICIN; ECHOCARDIOGRAPHY; HEART; HEART RATE; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIUM; RATS, WISTAR; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84925686118     PISSN: 09673334     EISSN: 13616579     Source Type: Journal    
DOI: 10.1088/0967-3334/36/4/727     Document Type: Article

References (39)

1. Aziriova S et al 2014 Doxorubicin-induced behavioral disturbances in rats: protective effects of melatonin and captopril Pharmacol. Biochem. Behav. 124 284-9
2. Baselli G, Cerutti S, Civardi S, Malliani A and Pagani M 1988 Cardiovascular variability signals: towards the identification of a closed-loop model of the neural control mechanisms IEEE Trans. Biomed. Eng. 35 1033-46
3. Bertinchant J P et al 2003 Evaluation of cardiac tropinin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings Clin. Chim. Acta 329 39-51
4. Brennan M, Palaniswami M and Kamen P 2002 Poincaŕe plot interpretation using a physiological model of HRV based on a network of oscillators Am. J. Physiol. Heart Circ. Physiol. 283 H1873-86
5. Cardinale D et al 2004 Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2749-54
6. Chatterjee K, Zhang J, Honbo N and Karliner J S 2010 Doxorubicin cardiomyopathy Cardiology 115 155-62
7. Chu E and Sartorelli A C 2009 Cancer chemotherapy Basic and Clinical Pharmacology 11th edn ed B G Katzung et al (New York: McGrawHill) 935-62
8. Curigliano G et al 2012 Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines Ann. Oncol. 23 vii155-66
9. Dolci A, Dominici R, Cardinale D, Sandri M T and Panteghini M 2008 Biochemical markers for prediction of chemotherapy-induced cardiotoxicity Am. J. Clin. Pathol. 130 688-95
10. Feng Y, Chai J, Chu W, Ma L, Zhang P and Duan H 2013 Combination of ketamine and xylazine exacerbates cardiac dysfunction in severely scalded rats during the shock stage Exp. Ther. Med. 6 641-8
11. Huang N E, Shen Z, Long S R, Wu M C, Shih H H, Zheng Q, Yen N, Tung C and Liu H H 1998 The empirical mode decomposition and Hilbert spectrum for nonlinear and non-stationary time series analysis Proc. R. Soc. Lond. A 454 903-95
12. Huikuri H V and Stein P K 2013 Heart rate variability in risk stratification of cardiac patients Prog. Cardiovasc. Dis. 56 153-9
13. Japundzic N, Grichois M L, Zitoun P, Laude D and Elghozi J L 1990 Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers J. Auton. Nerv. Syst. 30 91-100
14. Japundzic-Zigon N 1998 Physiological mechanisms in regulation of blood pressure fast frequency variations Clin. Exp. Hypertens. 20 359-88
15. Larue C, Calzolari C, Bertinchant J P, Leclerq F, Grolieau R and Pau B 1993 Cardiac-specific immune-enzymometric assay of tropinin I in the early phase of acute myocardial infarction Clin. Chem. 342 1220-2
16. Loncar-Turukalo T, Japundzic-Zigon N and Bajic D 2011 Temporal sequence parameters in isodistributional surrogate data: model and exact expressions IEEE Trans. Biomed. Eng. 58 16-24
17. Malfatto G, Branzi G, Gritti S, Sala L, Bragato R, Perego G B, Leonetti G and Facchini M 2001 Different baseline sympathovagal balance and cardiac autonomic responsiveness in ischemic and non-ischemic congestive heart failure Eur. J. Heart Fail. 3 197-202
18. May C N, Yao S T, Booth L C and Ramchandra R 2013 Cardiac sympathoexcitation in heart failure Auton. Neurosci.: Basic Clin. 175 76-84
19. Merlet N, Piriou N, Rozec B, Grabherr A, Lauzier B, Trochu J N and Gauthier C 2013 Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat Plos One 8 e64711
20. Nicolini P, Ciulla M M, De Asmundis C, Magrini F and Brugada P 2012 The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathovagal balance to chaos theory Pacing Clin. Electrophysiol. 35 622-38
21. Noussian T, Vanninen E, Jantunen E, Remes J, Ritanen E, Vuolteenaho O and Hartikainen J 2001 Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients Clin. Sci. 101 601-7
22. Octavia Y, Tocchetti C G, Gabrielson K L, Janssens S, Crijns H and Moens A L 2012 Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies J. Mol. Cell. Cardiol. 52 1213-25
23. Pagani M, Montano N, Porta A, Malliani A, Abboud F M, Birkett C and Somers V K 1997 Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans Circulation 95 1441-8
24. Pai V B and Nahata M C 2000 Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention Drug Saf. 22 263-302
25. Pellegrino P R, Schiller A M and Zuker I H 2014 Validation of pulse rate variability as surrogate for heart rate variability in chronically instrumented rabbits Am. J. Physiol. Heart Circ. Physiol. 307 H97-109
26. Piskorski J and Guzik P 2007 Geometry of the Poincare plot of RR intervals and its asymmetry in healthy adults Physiol. Meas. 28 287-300
27. Ponikowski P et al 1997 Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am. J. Cardiol. 79 1645-50
28. Robinson T W and Giri S N 1986 Effects of chronic administration of doxorubicin on myocardial beta-adrenergic receptors Life Sci. 39 731-6
29. Sawaya H et al 2011 Early detection and predicition of cardiotoxicity in chemotherapy-treated patients Am. J. Cardiol. 107 1375-80
30. Stein P K, Domitrovich P P, Huikuri H V and Kleiger R E 2005 Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction J. Cardiovasc. Electrophysiol. 16 13-20
31. Stein A B, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard M F, Tang X L, Bolli R and Dawn B 2007 Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats Basic Res. Cardiol. 102 28-41
32. Stojičić S, Milutinović-Smiljanić S, Šarenac O, Milosavljević S, Paton J F, Murphy D and Japundžić-Žigon N 2008 Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats Neuropharmacology 54 824-36
33. Task force of the European Society of Cardiology and the North American society of Pacing and Electrophysiology 1996a Heart rate variability: standards of measurement, physiological interpretation, and clinical use Eur. Heart J. 17 354-81
34. Task force of the European Society of Cardiology and the North American society of Pacing and Electrophysiology 1996b Heart rate variability: standards of measurement, physiological interpretation, and clinical use Circulation 93 1043-65
35. Teraoka K, Hirano M, Yamaguchi K and Yamashina A 2000 Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats Eur. J. Heart Fail. 2 373-8
36. Tjeerdsma G, Meinardi M T, van der Graaf W T A, van den Berg M P, Mulder N H, Crijns H J G M, de Vries E G and van Veldhuisen D J 1999 Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables Heart 81 419-23
37. Tong J, Ganguly P K and Singal P K 1991 Myocardial adrenergic changes at two stage of heart failure due to adriamycin treatment in rats Am. J. Physiol. Heart Circ. Physiol. 29 H909-16
38. Ungerer M, Bohm M, Elce J S, Erdmann E and Lohse M J 1993 Altered expression of beta-adrenergic receptor kinase and beta 1- adrenergic receptors in the failing human heart Circulation 87 454-63
39. Vasic M and Japundzic-Zigon N 2014 G protein receptor kinase type 2: a novel target in cardiovascular drug development Hospital Pharmacol. 1 109-14